Source:http://linkedlifedata.com/resource/pubmed/id/12467234
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006812,
umls-concept:C0017817,
umls-concept:C0035820,
umls-concept:C0205360,
umls-concept:C0333668,
umls-concept:C0439855,
umls-concept:C0441655,
umls-concept:C0596311,
umls-concept:C1160466,
umls-concept:C1330957,
umls-concept:C1336767,
umls-concept:C1554184,
umls-concept:C1709059,
umls-concept:C2349975
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-12-6
|
pubmed:abstractText |
Depletion of glutathione (GSH) in MCF-7 and MDA-MB-231 cell lines by pretreatment with the GSH synthesis inhibitor buthionine sulfoximine potentiated the activity of 10,11-methylenedioxy-20(S)-camptothecin, SN-38 [7-ethyl-10-hydroxy-20(S)-camptothecin], topotecan, and 7-chloromethyl-10,11-methylenedioxy-20(S)-camptothecin (CMMDC). The greatest potentiation was observed with the alkylating camptothecin CMMDC. Buthionine sulfoximine pretreatment also increased the number of camptothecin-induced DNA-protein crosslinks, indicating that GSH affects the mechanism of action of camptothecin. We also report that GSH interacts with CMMDC to form a stable conjugate, 7-(glutathionylmethyl)-10,11-methylenedioxy-20(S)-camptothecin (GSMMDC), which is formed spontaneously in buffered solutions and in MCF-7 cells treated with CMMDC. GSMMDC was synthesized and found to be nearly as active as 10,11-methylenedioxy-20(S)-camptothecin in a topoisomerase (topo) I-mediated DNA nicking assay. The resulting topo I cleavage complexes were remarkably stable. In cell culture, GSMMDC displayed potent growth-inhibitory activity against U937 and P388 leukemia cell lines. GSMMDC was not active against a topo I-deficient P388 cell line, indicating that topo I is its cellular target. Peptide-truncated analogues of GSMMDC were prepared and evaluated. All three derivatives [7-(gamma-glutamylcysteinylmethyl)-10,11-methylenedioxy-20(S)-camptothecin, 7-(cysteinylglycylmethyl)-10,11-methylenedioxy-20(S)-camptothecin, and 7-(cysteinylmethyl)-10,11-methylenedioxy-20(S)-camptothecin] displayed topo I and cell growth-inhibitory activity. These results suggest that 7-peptidyl derivatives represent a new class of camptothecin analogues.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/Buthionine Sulfoximine,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1535-7163
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-20
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12467234-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:12467234-Buthionine Sulfoximine,
pubmed-meshheading:12467234-Camptothecin,
pubmed-meshheading:12467234-Chromatography, High Pressure Liquid,
pubmed-meshheading:12467234-DNA, Neoplasm,
pubmed-meshheading:12467234-DNA Topoisomerases, Type I,
pubmed-meshheading:12467234-Drug Synergism,
pubmed-meshheading:12467234-Female,
pubmed-meshheading:12467234-Glutathione,
pubmed-meshheading:12467234-Humans,
pubmed-meshheading:12467234-Magnetic Resonance Spectroscopy,
pubmed-meshheading:12467234-Mass Spectrometry,
pubmed-meshheading:12467234-Structure-Activity Relationship,
pubmed-meshheading:12467234-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complex.
|
pubmed:affiliation |
Department of Medicine, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina 27710, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|